Controlled Release Oral Drug Delivery System

Controlled Release Oral
Drug Delivery System
Bhupendra Kumar Yadav M.Pharm
University Institute of Pharmacy
Pt.Ravishankar Shukla University Raipur-492010, Chhattishgarh, India
E-mail: byadav48@gmail.com

2
Contents
 Overview of Digestive system
 Introduction
 Advantages
 Disadvantages
 Mechanisms
1.Dissolution
2.Diffusion
3.Combination of Dissolution & Diffusion
4.Osmotic pressure controlled system
 References

4
Concept
 Controlled drug delivery is one which
delivers the drug at a predetermined rate,
for locally or systemically, for a specified
period of time.
 Continuous oral delivery of drugs at
predictable & reproducible kinetics for
predetermined period throughout the
course of GIT.

5
Plasma concentration time profile

6
Challenges in Oral
Drug Delivery
 Development of drug delivery system
Delivering a drug at therapeutically effective rate to
desirable site.
 Modulation of GI transit time
Transportation of drug to target site.
 Minimization of first pass elimination

7
Advantages
 Total dose is low.
 Reduced GI side effects.
 Reduced dosing frequency.
 Better patient acceptance and compliance.
 Less fluctuation at plasma drug levels.
 More uniform drug effect
 Improved efficacy/safety ratio.

8
Disadvantages
 Dose dumping.
 Reduced potential for accurate dose adjustment.
 Need of additional patient education.
 Stability problem.

9
Mechanism aspects of Oral drug
delivery formulation
1.Dissolution : 1.Matrix
2.Encapsulation
2.Diffusion : 1.Matrix
2.Reservoir
3.Combination of both dissolution & diffusion.
4.Osmotic pressure controlled system

10
Dissolution Definition:
 Solid substances solubilizes in a given
solvent.
 Mass transfer from solid to liquid.
 Rate determining step: Diffusion from solid
to liquid.
 Several theories to explain dissolution –
Diffusion layer theory (imp)
Surface renewal theory
Limited solvation theory.

11
Noyes Whitney Equation
dc/dt = kD.A (Cs – C )
dc/dt = D/h A. (Cs – C)
dc/dt = Dissolution rate.
k= Dissolution rate constant (1st order).
D = Diffusion coefficient/diffusivity
Cs = Saturation/ maximum drug solubility.
C =Con. Of drug in bulk solution.
Cs-C=concentration gradient.
h =Thickness of diffusion layer.

12
Matrix Type
 Also called as Monolith dissolution
controlled system.
 Controlled dissolution by:
1.Altering porosity of tablet.
2.Decreasing its wettebility.
3.Dissolving at slower rate.
 First order drug release.
 Drug release determined by
dissolution rate of polymer.
 Examples: Dimetane extencaps,
Dimetapp extentabs.
Soluble drug
Slowly
dissolving
matrix

13
Encapsulation
 Called as Coating dissolution
controlled system.
 Dissolution rate of coat depends
upon stability & thickness of
coating.
 Masks
colour,odour,taste,minimising GI
irritation.
 One of the microencapsulation
method is used.
 Examples: Ornade spansules,
Chlortrimeton Repetabs
Soluble drug
Slowly
dissolving
or erodible
coat

14
Diffusion
 Major process for absorption.
 No energy required.
 Drug molecules diffuse from a region of higher concentration to
lower concentration until equilibrium is attainded.
 Directly proportional to the concentration gradient across the
membrane.

15
Matrix Diffusion Types
 Rigid Matrix Diffusion
Materials used are insoluble plastics such as PVP & fatty
acids.
 Swellable Matrix Diffusion
1. Also called as Glassy hydrogels.Popular for sustaining
the release of highly water soluble drugs.
2. Materials used are hydrophilic gums.
Examples : Natural- Guar gum,Tragacanth.
Semisynthetic -HPMC,CMC,Xanthum
gum.
Synthetic -Polyacrilamides.
Examples: Glucotrol XL, Procardia XL

16
Matrix system
Rate controlling
step:
Diffusion of dissolved
drug in matrix.

17
Higuchi Equation
Q = DE/T (2A.E Cs)Cs.t)1/2
Where ,
Q=amt of drug release per unit surface area at time t.
D=diffusion coefficient of drug in the release medium.
E=porosity of matrix.
Cs=solubility of drug in release medium.
T=tortuosity of matrix.
A=concentration of drug present in matrix per unit
volume.

18
Reservoir System
 Also called as Laminated matrix device.
 Hollow system containing an inner core surrounded
in water insoluble membrane.
 Polymer can be applied by coating or micro
encapsulation.
 Rate controlling mechanism - partitioning into
membrane with subsequent release into surrounding
fluid by diffusion.
 Commonly used polymers - HPC, ethyl cellulose &
polyvinyl acetate.
 Examples: Nico-400, Nitro-Bid

19
Reservoir System
Rate controlling
steps :
Polymeric content in
coating, thickness of
coating, hardness of
microcapsule.

Entry of
dissolution
fluid
Drug
diffusion
20
Dissolution & Diffusion
Controlled Release system
 Drug encased in a partially soluble
membrane.
 Pores are created due to dissolution
of parts of membrane.
 It permits entry of aqueous medium
into core & drug dissolution.
 Diffusion of dissolved drug out of
system.
 Ex- Ethyl cellulose & PVP mixture
dissolves in water & create pores of
insoluble ethyl cellulose membrane.
Insoluble
membrane
Pore created by
dissolution of
soluble fraction of
membrane

21
Osmotic Pressure Controlled
Drug Delivery System
 Definition
 Procedure
 Diagram
 Modifications

22
Osmosis
- Movement of solvent from lower to higher concentration.
- The passage of solvent into a solution through
semipermeable membrane.
Semipermeable Membrane
Molecules are permitted only to one component
(Water).
Osmotic pressure
It is the hydrostatic pressure produced by a solution
in a space divided by a semipermeable membrane
due to difference in concentration of solutes.

23
System
 Provides zero order release
 Drug may be osmotically active, or combined with an
osmotically active salt (e.g., NaCl).
 Semipermeable membrane usually made from cellulose
acetate.
 More suitable for hydrophilic drug.
 Examples: Glucotrol XL, Procardia XL,

24
Equation
(Q/t) z = Pw Am/ hm (πs-πe )
(Q/t)= Rate of zero order drug release.
Pw, Am & hm= water permeability, effective surface
area & thickness of semipermeable membrane.
πs= osmotic pressure of saturated solution of
osmotically active drug or salt in system.
πe = osmotic pressure of GI fluid.

25
System

26
System

Modifications
- Immediate release system.
- Osmotically active compartment system

28
Immediate Release System
 Activation of system is done.
 Dividing a dose into two parts.
 One third immediate release.
 Two third controlled release.
 Encapsulated into semipermeable
membrane.
e.g. : Phenyl propanolamine.

29
Osmotically active system
 Two compartments
separated by movable
partition.
 Osmotically active
compartment absorbs
water from GIT.
 Creates osmotic
pressure.
 Partition moves
upward & then drug
releases.
 Ex: Nifedipine.
Movable
partition
Delivery orifice
Drug compartment
Osmotically active
compartment

30
Some Popular Brand names used
for OCDDS
 Spansule capsule ( SK & F )
 Sequal capsule (Lederle )
 Extentab tablets ( Robins )
 Timespan tablet ( Roche )
 Dospan tablet ( Merrell Dow )
 Chronotab tablet ( Schering )
 Plateau capsule ( Marion )
 Tempule capsule ( Armour )

31
Some Examples of OCDDS
 Propranolol (Inderal LA)
 Methyiphenidate HCl (RitalinSR)
 Iron (Slow-Fe)
 GITS-Prazosin (Minipress)
 Morphine sulfate (Roxanol SR)
 Decongestant & antihistamine (Resaid SR, Novafed SR
Dristan)
 Pseudoephedrine HCI (Sudafed SA)
 Potassium (Micro-K, Slow-K, Klotrix)
 Antitussive combinations (Rescap, Ornade Spansules)
 Chlorpheniramine maleate (ChlorTrimeton)
 Decongestant, antihistamine and anticholinergic (Dallergy,
Supres)

32
Recent Trends : Extended release
formulation of Bupropion
 Bupropion is used in the treatment of major depressive
disorder.
 Conventional formulation has to be administered 3 times
daily
 Initially 150 mg ER formulation was introduced for bid
regimen
Later on 300 mg ER formulation was introduced for once
daily regimen
 For ER formulation provide similar Cmax and AUC values
as compared to immediate release formulation at steady
state.

33
Recent Trends : Extended release
formulation of Bupropion

34
Recent Trends: OROS Technology
(ALZA corporation)
 Single layer tablet: Drug
core (water soluble drug
with or without excipients)
 Semipermeable membrane
with a drilled orifice
 Water imbibition by the core
because of osmotic action
results in drug dissolution,
which is released at a
controlled rate through the
orifice
ELEMENTARY OSMOTIC PUMP
 Not suitable for water insoluble drugs.
 Examples: Sudafed 24
hours (Pseudoephedrine); Volmax (Salbutamol)

Recent trends: Geomatrix® (SKY Parma)
35
Products in market:
Cordicant -uno®
Madopar DR
SULAR ER
This technology Controls amount,
timing and location of release in
body.
-Formulation with predictable and
reproducible drug release profile.
-Controls rate of drug diffusion
throughout release process,
ensuring 100% release Products

36
References
 Novel drug delivery system , volume 50,
Y.W.Chien
 The theory & practice of industrial pharmacy,
Leon Lachman , Herbert A.Lieberman,
Joseph L.Kanig,3 rd edition.
 The Eastern pharmacist, november 1993.
Sustained release drugs, V R.Gudsoorkar & D.Rambhau
page 27-32
 Biopharmaceuitics & pharmacokinetics,
D M.Brahmankar & Sunil B. Jaiswal.
www.google.com

37
Thank you for paying
attention…
If this presentation was
useful to u, then please
click like button

Controlled Release Oral Drug Delivery System

More Related Content

What's hot (20)

Viewers also liked (10)

Similar to Controlled Release Oral Drug Delivery System (20)

Recently uploaded (20)

Controlled Release Oral Drug Delivery System